Nutex Health faces shareholder lawsuit over alleged fraudulent conduct.

• Nutex Health Inc. shareholder class action lawsuit filed • Allegations of false and misleading statements and/or omitted material information • Claims of fraudulent conduct in arbitration results and unsustainable revenues • Overstatement of remediation efforts and inability to account for stock-based compensation • Material weaknesses in internal controls over financial reporting • Unsustainable revenues due to fraudulent conduct • Overstatement of remediation efforts • Inability to account for stock-based compensation • Material weaknesses in internal controls over financial reporting

July 02, 2025 - A class action lawsuit has been filed against Nutex Health Inc. (NUTX), alleging that the company made materially false and/or misleading statements and failed to disclose material adverse information regarding its business, operations, and prospects. The lawsuit, filed on behalf of investors, seeks to recover economic losses stemming from the alleged misconduct.

The lawsuit, filed in the United States District Court for the Southern District of Texas, alleges several key points:

1. False and Misleading Statements: The defendants are accused of making false and misleading statements about Nutex’s business, operations, and prospects. This includes claims that revenues were unsustainable due to fraudulent conduct in arbitration results.

2. Omitted Material Information: The lawsuit also alleges that Nutex failed to disclose material adverse information, such as the true extent of its remediation efforts and its ability to account for stock-based compensation.

3. Fraudulent Conduct: Specifically, the lawsuit claims that HaloMD, a company involved with Nutex, was engaging in a coordinated scheme to defraud insurance companies, leading to unsustainable revenues.

4. Material Weaknesses in Internal Controls: Nutex is accused of overstating its ability to remediate material weaknesses in its internal controls over financial reporting, which resulted in improper accounting for stock-based compensation.

The lawsuit seeks to appoint a lead plaintiff by October 21, 2025. Investors who purchased Nutex shares between August 8, 2024, and August 14, 2025, and experienced significant losses are encouraged to contact legal counsel to discuss their rights.

Investors with losses in excess of $100,000 are urged to file lead plaintiff applications by the deadline. They may contact Kahn Swick & Foti, LLC, a top-rated securities litigation law firm, for more information [1].

References

[1] https://www.morningstar.com/news/business-wire/20250825719506/nutex-health-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-nutex-health-inc-nutx
[2] https://www.morningstar.com/news/globe-newswire/9517612/investor-alert-class-action-lawsuit-filed-on-behalf-of-nutex-health-inc-nutx-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-firm